Atlanta-based BioShield Technologies Inc. announced that it has signed a distribution agreement
with Apollo Chemical Corp., Burlington, N.C., to distribute BioShields patented antimicrobial
products, AM500 and BST1860. Annual sales are estimated at $1 million.This agreement with BioShield
Technologies Inc. allows Apollo Chemical to offer an EPA-registered, patented antimicrobial
technology to our customers in the United States and overseas, said Ed Rish, vice president,
Apollo.Tim Moses, president and CEO, BioShield, stated, We are very pleased with our agreement with
Apollo Chemical, a company that is clearly a leader in the textile chemical industry. We are
equally excited about their ability to provide their clients with the antimicrobial agent theyve
needed.
December 2000
